Regulation and phenotype of an innate Th1 cell: Role of cytokines and the p38 kinase pathway

被引:37
|
作者
Yu, JJ
Tripp, CS
Russell, JH
机构
[1] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[2] Pharmacia Corp, Dept Arthrit & Inflammat Pharmacol, St Louis, MO 63198 USA
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 11期
关键词
D O I
10.4049/jimmunol.171.11.6112
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have explored the phenotype and regulation of Th1 cell activation by the cytokines IL-12 and IL-18. We demonstrate that these two cytokines selectively induce IFN-gamma in a differentiated Th1 cell population through the previously described p38 mitogen-activated protein (MAP) kinase pathway. Using a highly selective p38 MAP kinase inhibitor, we demonstrate that it is possible to block IFN-gamma induction from activated, differentiated Th1 cells via p38 MAP kinase without disrupting the activation and differentiation of naive T cells or the proliferation of naive or differentiated T cells. In addition, IL-12 and IL-18 provide an All and IL-2-independent survival signal to this uniquely differentiated Th1 cell population. We hypothesize that this Ag-independent survival of Th1 cells may participate in an innate inflammatory loop with monocytes at the sites of chronic inflammation. In addition, p38 MAP kinase inhibition of this cytokine-regulated pathway may be a unique mechanism to inhibit chronic inflammation without disruption of Ag-driven activation and function of naive T cells.
引用
收藏
页码:6112 / 6118
页数:7
相关论文
共 50 条
  • [1] Involvement of p38 in the regulation of inflammatory and Th1/Th2 cytokines
    Gupta, S
    Crouse, S
    Chou, J
    Shuman, R
    Reagan, K
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 34 - 34
  • [2] The Regulation of Th1 Responses by the p38 MAPK
    Yang, Ziyan
    Zhang, Xia
    Darrah, Patricia A.
    Mosser, David M.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (10): : 6205 - 6213
  • [3] The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells
    DeSilva, DR
    Jones, EA
    Feeser, WS
    Manos, EJ
    Scherle, PA
    CELLULAR IMMUNOLOGY, 1997, 180 (02) : 116 - 123
  • [4] Using new Luminex and phosphoELISA technology to show the involvement of p38 in the regulation of inflammatory and Th1/Th2 cytokines
    Crouse, S
    Wang, J
    Chou, J
    Simson, M
    Reagan, K
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 24A - 24A
  • [5] Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
    Rincón, M
    Enslen, H
    Raingeaud, J
    Recht, M
    Zapton, T
    Su, MSS
    Penix, LA
    Davis, RJ
    Flavell, RA
    EMBO JOURNAL, 1998, 17 (10): : 2817 - 2829
  • [6] A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity
    Kim, DH
    Feinbaum, R
    Alloing, G
    Emerson, FE
    Garsin, DA
    Inoue, H
    Tanaka-Hino, M
    Hisamoto, N
    Matsumoto, K
    Tan, MW
    Ausubel, FM
    SCIENCE, 2002, 297 (5581) : 623 - 626
  • [7] Role of cell volume regulation and p38 MAP kinase in neutrophil migration.
    Henson, PM
    Rosengren, S
    Young, S
    Janes, M
    Worthen, GS
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 24 - 24
  • [8] Cytokines, p38 MAP Kinase and the Pathophysiology of Depression
    Andrew H Miller
    Charles L Raison
    Neuropsychopharmacology, 2006, 31 : 2089 - 2090
  • [9] A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp
    del Arco, PG
    Martínez-Martinez, S
    Maldonado, JL
    Ortega-Pérez, I
    Redondo, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) : 13872 - 13878
  • [10] Cytokines, p38 MAP kinase and the pathophysiology of depression
    Miller, Andrew H.
    Raison, Charles L.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (10) : 2089 - 2090